↓ Skip to main content

Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study

Overview of attention for article published in BMC Musculoskeletal Disorders, April 2011
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
37 Mendeley
Title
Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
Published in
BMC Musculoskeletal Disorders, April 2011
DOI 10.1186/1471-2474-12-71
Pubmed ID
Authors

Gelsomina L Borromeo, Caroline Brand, John G Clement, Michael McCullough, Wendy Thomson, Elly Flitzanis, John D Wark

Abstract

Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to duration of exposure and hence cumulative dose, dental interventions, medical co-morbidities or in some circumstances with no identifiable aggravating factor. While jaw osteonecrosis is a devastating outcome which is currently difficult to manage, various forms of delayed dental healing may be a less dramatic and, therefore, poorly-recognised complications of bisphosphonate use for the treatment of osteoporosis. It is hypothesised that long-term (more than 1 year's duration) bisphosphonate use for the treatment of post-menopausal osteoporosis or other benign bone disease is associated with impaired dental healing.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 5%
Taiwan 1 3%
Unknown 34 92%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 19%
Professor > Associate Professor 5 14%
Unspecified 4 11%
Student > Doctoral Student 4 11%
Student > Master 4 11%
Other 13 35%
Readers by discipline Count As %
Medicine and Dentistry 24 65%
Unspecified 5 14%
Agricultural and Biological Sciences 4 11%
Immunology and Microbiology 2 5%
Decision Sciences 1 3%
Other 1 3%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2011.
All research outputs
#10,995,906
of 12,373,620 outputs
Outputs from BMC Musculoskeletal Disorders
#2,252
of 2,454 outputs
Outputs of similar age
#191,795
of 225,470 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#27
of 27 outputs
Altmetric has tracked 12,373,620 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,454 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,470 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.